BM8 fundamentals
An in-depth look to BIOMARIN PHAR. DL-,001 operating, investing, and financing activities
BM8 free cash flow for Q1 24 is 19.34 M EUR. For 2023, BM8 free cash flow was 56.69 M EUR and operating cash flow was 144.29 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM